The global tuberculosis testing market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increase in the number of infected cases around the world, increased health awareness, and notable steps taken by various governments of developing countries. Early tuberculosis (TB) screening and testing is an important method for controlling and avoiding illness.
Tuberculosis (TB), as one of the world's most common infectious diseases, is caused due to the infection with a bacteria called Mycobacterium tuberculosis, a member of the Mycobacteria group (MTB). TB infection can also be caused by other agents including M. africanum and M. bovis. Tuberculosis is generally spread through respiratory droplets from one person to another and the bacteria causing TB are mostly present in the lungs, which can also affect the kidney, gut, pleura, spine, and brain without proper treatment. The most appropriate tests for detecting M. tuberculosis infection is primarily chosen based on the testing context, test availability, and overall cost effectiveness.
Tuberculosis usually affects the lungs, but it can also affect the genitourinary system, lymphatic system, and central nervous system. Pulmonary Tuberculosis is a type of TB that affects the lungs, while extrapulmonary tuberculosis affects other parts of the body. Chronic cough, night sweats, blood-tinged sputum, and fever are the most common TB symptoms. According to a report published by World Trade Organization (WTO), 1.3 million people are died from the TB every year. The identification of Multi Drug Resistant (MDR) adds to the treatment's complexity because standard drugs cannot be utilized to treat the disease. Early detection of tuberculosis allows for more successful therapy. As a result, rapid identification tests are carried out in either research laboratories or hospitals.
During the COVID-19 pandemic, the global tuberculosis diagnostics market has slowed down as the disease forced both public and private groups to concentrate their efforts on developing COVID-19-specific testing kits. This resulted in a substantial scarcity of tuberculosis diagnostic kits. Moreover, most of the resources were diverted to use for manufacturing COVID-19 testing kits and research and development purposes.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing number of TB cases and infection diseases globally as well as increasing adoption of the TB diagnostic kit for early detection of the disease are expected to drive the market growth during the forecast period. ,
- Growing awareness about the benefits for early diagnostics to detect TB and prominent policies implemented by several government bodies of various developing nations are anticipated to boost the market growth during forecast period.
- Development of innovated and hybrid technique for multiple disorder detection and effective analysis of TB testing are projected to restrict the market growth.
- High cost of the diagnosis and time consumption for test are the major restraining factors which are expected to hamper the growth market.
- Ongoing R&D activities to develop advanced TB testing devices and other diagnostics kits are creating several opportunities for the market expansion.
Scope of the Report
The report on the global tuberculosis testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Tuberculosis Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Test Methods (Routine Methods [Skin Test] and Rapid Methods [Polymerase Chain Reaction, Cassette Test, Microscopic Observation Drug Susceptibility, and Enzyme Linked Immunosorbent Spot Test]) and End-users (Laboratories and Hospitals) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Orasure technologies, Originate ventures, and Labcorp. |
Market Segment Insights
Skin test segment is projected to account for a key market share
Based on test methods, the tuberculosis testing market is bifurcated into routine methods and rapid methods. The routine methods segment consists of skin test. Similarly, the rapid method is further divided into polymerase chain reaction, cassette test, microscopic observation drug susceptibility, and enzyme linked immunosorbent spot test. The skin test segment is expected to represent a key share of the market during the forecast period owing to its ability to conduct fast tests and generates the report rapidly. Growing adoption of skin tests as a part of TB diagnostic procedures and treatment is projected to boost the segment growth.
Hospital segment is anticipated to expand at a substantial CAGR
In terms of end-users, the tuberculosis testing market is bifurcated into laboratories and hospitals. The hospital segment is expected to represent a key share of the market during the forecast period owing to its easy availability and accessibility. Patients are generally preferred to visit hospitals due to certain advantages such as availability of specialized doctors and medical staff along with the wide installation of advanced diagnostic devices.
North America is anticipated to dominate the market
On the basis of regions, the tuberculosis testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to expand at an impressive CAGR during the forecast period owing to increase cases of TB due to rising numbers of homeless shelters, jails, or some nursing homes. According to the WTO research, Europe and Asia Pacific represent a big portion of TB patients in the global market, with India and China alone having more than 5 million tuberculosis patients, implying a substantial increase in the number over the next six years.
Segments
Segments Covered in the Report
The global tuberculosis testing market has been segmented on the basis of
Test methods
- Routine Methods
- Skin Test
- Rapid Methods
- Polymerase Chain Reaction
- Cassette Test
- Microscopic Observation Drug Susceptibility
- Enzyme Linked Immunosorbent Spot Test
End-users
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Orasure technologies
- Originate ventures
- Labcorp
Competitive Landscape
Key players competing in the global tuberculosis testing market are Orasure technologies, Originate ventures, and Labcorp. These players are actively engaged in various market strategies such as product launches, mergers, partnerships, collaborations, and production capacity expansion to enhance their market positions.
Request For Customization
Enquiry Before Buying
Speak With Analyst
